Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Scholl

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Home Healthcare Nurse|September 1, 1987
Neuroleptic malignant syndromeM D Scholl
Journal of the Royal Society of Medicine|November 1, 1989
The Zed Expedition: the world's first air ambulance?M D Scholl, C L Geshekter
Bone Marrow Transplantation|September 12, 2001
Busulfan levels are influenced by prior treatment and are associated with hepatic veno-occlusive disease and early mortality but not with delayed complications following marrow transplantationE A Copelan, T P Bechtel, B R Avalos, et al.
Bone Marrow Transplantation|June 29, 2000
Analysis of prognostic factors for allogeneic marrow transplantation following busulfan and cyclophosphamide in myelodysplastic syndrome and after leukemic transformationE A Copelan, S L Penza, P J Elder, et al.
Bone Marrow Transplantation|April 1, 1996
Bone marrow engraftment following unrelated donor transplantation utilizing busulfan and cyclophosphamide preparatory chemotherapyJ L Klein, B R Avalos, P Belt, et al.
Bone Marrow Transplantation|May 25, 2004
Therapy-related myelodysplasia and leukemia occur infrequently following VP-16 priming and autotransplantation without total body irradiationE Copelan, S Hoshaw-Woodard, P Elder, et al.
Bone Marrow Transplantation|November 1, 1996
Influence of graft-versus-host disease on outcome following allogeneic transplantation with radiation-free preparative therapy in patients with advanced leukemiaE A Copelan, S L Penza, P J Elder, et al.
Bone Marrow Transplantation|December 7, 2000
The influence of early transplantation, age, GVHD prevention regimen, and other factors on outcome of allogeneic transplantation for CML following BuCyE A Copelan, S L Penza, K S Theil, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Mobilization of peripheral-blood progenitor cells with high-dose etoposide and granulocyte colony-stimulating factor in patients with breast cancer, non-Hodgkin's lymphoma, and Hodgkin's diseaseE A Copelan, S K Ceselski, S A Ezzone, et al.
Bone Marrow Transplantation|June 29, 2000
Autotransplantation following busulfan, etoposide and cyclophosphamide in patients with non-Hodgkin's lymphomaE A Copelan, S L Penza, B Pohlman, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Home Healthcare Nurse|September 1, 1987
Neuroleptic malignant syndromeM D Scholl
Journal of the Royal Society of Medicine|November 1, 1989
The Zed Expedition: the world's first air ambulance?M D Scholl, C L Geshekter
Bone Marrow Transplantation|September 12, 2001
Busulfan levels are influenced by prior treatment and are associated with hepatic veno-occlusive disease and early mortality but not with delayed complications following marrow transplantationE A Copelan, T P Bechtel, B R Avalos, et al.
Bone Marrow Transplantation|June 29, 2000
Analysis of prognostic factors for allogeneic marrow transplantation following busulfan and cyclophosphamide in myelodysplastic syndrome and after leukemic transformationE A Copelan, S L Penza, P J Elder, et al.
Bone Marrow Transplantation|April 1, 1996
Bone marrow engraftment following unrelated donor transplantation utilizing busulfan and cyclophosphamide preparatory chemotherapyJ L Klein, B R Avalos, P Belt, et al.
Bone Marrow Transplantation|May 25, 2004
Therapy-related myelodysplasia and leukemia occur infrequently following VP-16 priming and autotransplantation without total body irradiationE Copelan, S Hoshaw-Woodard, P Elder, et al.
Bone Marrow Transplantation|November 1, 1996
Influence of graft-versus-host disease on outcome following allogeneic transplantation with radiation-free preparative therapy in patients with advanced leukemiaE A Copelan, S L Penza, P J Elder, et al.
Bone Marrow Transplantation|December 7, 2000
The influence of early transplantation, age, GVHD prevention regimen, and other factors on outcome of allogeneic transplantation for CML following BuCyE A Copelan, S L Penza, K S Theil, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Mobilization of peripheral-blood progenitor cells with high-dose etoposide and granulocyte colony-stimulating factor in patients with breast cancer, non-Hodgkin's lymphoma, and Hodgkin's diseaseE A Copelan, S K Ceselski, S A Ezzone, et al.
Bone Marrow Transplantation|June 29, 2000
Autotransplantation following busulfan, etoposide and cyclophosphamide in patients with non-Hodgkin's lymphomaE A Copelan, S L Penza, B Pohlman, et al.
Pageof 1